Table 1

Characteristics of study population by gender and serum uric acid quartile

Women (n = 1,287)

Men (n = 1,211)

Quartile 1

Quartile 2

Quartile 3

Quartile 4

Quartile 1

Quartile 2

Quartile 3

Quartile 4


sUA range, μmol/L [mg/dL]

77-196 [1.3-3.3]

196-226 [3.3-3.8]

232-274 [3.9-4.6]

280-636 [4.7-10.7]

155-291 [2.6-4.9]

297-333 [5.0-5.6]

339-393 [5.7-6.6]

399-690 [6.7-11.6]

Age, years

40.1 (3.8)

40.1 (3.6)

40.3 (3.6)

40.5 (3.8)

40.1 (3.6)

39.8 (3.5)

40.4 (3.5)

40.4 (3.6)

African-American

43.5%

42.6%

46.5%

57.5%

42.7%

37.4%

42.5%

43.2%

Body mass index, kg/m2

24.8 (4.7)

27.2 (6.2)

29.6 (6.8)

33.1 (7.2)

26.1 (3.8)

27.4 (4)

28.1 (4.5)

30.1 (4.6)

Alcohol, mL/day

6.2 (10)

5.7 (11.8)

9 (32.7)

9.1 (22)

13.3 (35.4)

14.2 (25.1)

16.2 (24.4)

20.3 (35.1)

Smokers

36.6%

39.7%

38%

46.2%

35.3%

39.4%

39.3%

40.2%

Systolic BP, mm Hg

107 (12.5)

109.3 (14)

112.4 (15.3)

115.5 (16.3)

111.7 (11.2)

114.8 (13.5)

115.4 (12.9)

118.3 (14.7)

Diastolic BP, mm Hg

69.6 (10.1)

71.5 (10.2)

73.3 (10.9)

75.9 (12.6)

73.3 (9.2)

76.3 (11)

76.8 (10.2)

79.2 (12.1)

Serum fasting glucose, mmol/L [mg/dL]

4.45 (0.40) [80.2 (7.2)]

4.48 (0.43) [80.7 (7.7)]

4.5 (0.45) [81.1 (8.1)]

4.7 (0.53) [84.3 (9.5)]

4.7 (0.46) [84 (8.3)]

4.8 (0.53) [85.7 (9.6)]

4.8 (0.52) [86.4 (9.4)]

4.9 (0.54) [88.8 (9.7)]

Serum HDL-C, mmol/L [mg/dL]

1.54 (0.33) [59.7 (12.8)]

1.44 (0.35) [55.5 (13.5)]

1.45 (0.36) [56 (14.1)]

1.32 (0.37) [51 (14.4)]

1.24 (0.33) [48 (12.9)]

1.19 (0.32) [45.9 (12.4)]

1.14 (0.31) [43.9 (11.8)]

1.10 (0.33) [42.4 (12.6)]

Serum LDL-C, mmol/L [mg/dL]

2.72 (0.73) [105.1 (28.2)]

2.74 (0.74) [105.9 (28.7)]

2.80 (7.7) [108.4 (29.8)]

3.01 (0.79) [116.3 (30.6)]

2.87 (0.74) [110.9 (28.5)]

3.12 (0.81) [120.5 (31.5)]

3.19 (0.95) [123.5 (36.6)]

3.23 (0.92) [125 (35.7)]

Serum triglycerides, mmol/L [mg/dL]

0.78 (0.38) [68.8 (33.8)]

0.89 (0.44) [78.7 (39.1)]

0.95 (0.52) [84.5 (45.8)]

1.27 (0.80) [112.6 (70.7)]

1.01 (0.67) [89.8 (59.7)]

1.26 (0.76) [111.5 (67.4)]

1.52 (1.87) [135 (165.7)]

1.86 (1.76) [164.8 (156.1)]

Serum creatinine, μmol/L [mg/dL]

79.6 (8.8) [0.9 (0.1)]

79.6 (8.8) [0.9 (0.1)]

79.6 (8.8) [0.9 (0.1)]

79.6 (8.8) [0.9 (0.1)]

97.2 (8.8) [1.1 (0.1)]

97.2 (8.8) [1.1 (0.1)]

97.2 (17.7) [1.1 (0.2)]

97.2 (17.7) [1.1 (0.2)]

Waist circumference, cm

76.6 (10.1)

81.6 (12.1)

86.3 (13.1)

94 (14.1)

87.8 (9.5)

91.8 (9.6)

93.5 (11)

98.4 (10.9)

eGFR, abbreviated MDRD

87.2 (15.1)

85.6 (15.5)

83.9 (14.2)

82.7 (15.2)

89.9 (13.6)

88.3 (14.1)

87.1 (19.3)

85.6 (16.1)

Framingham risk score

-4.8 (4.1)

-3.7 (4.3)

-3.3 (4.4)

-1.4 (4.3)

1.1 (2.2)

1.8 (2.4)

2.3 (2.3)

2.7 (2.4)

C-reactive protein, mg/dL

1.5 (2.9)

1.5 (1.7)

1.6 (2.9)

1.8 (1.7)

1.7 (2.9)

1.8 (2.0)

2.0 (2.5)

2.1 (2.5)


Data are presented as range, mean (standard deviation), or percentage. BP, blood pressure; eGFR, estimated glomerular filtration rate; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-density lipoprotein cholesterol; MDRD, modification of diet in renal disease; sUA, serum uric acid.

Krishnan et al. Arthritis Research & Therapy 2011 13:R66   doi:10.1186/ar3322

Open Data